Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Expanded Allogeneic Umbilical Cord Mesenchymal Cells in Preterm Bronchopulmonary Dysplasia
2024-516677-79-00Phase 2Authorised
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Sep 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of expanded allogeneic umbilical cord mesenchymal stem cells in bronchopulmonary dysplasia (BPD), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: Safety assessment: adverse reactions. Planned start Sep 2024; status: authorised.
02
Drugs
expanded allogeneic umbilical cord mesenchymal stem cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on 2024-516677-79-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516677-79-00.